NCLR Condemns Court Ruling on Medication Abortion
April 08, 2023
April 08, 2023
WASHINGTON, April 8 (TNStalk) -- The National Center for Lesbian Rights issued the following statement on April 7, 2023:
* * *
A federal judge in Texas, in the case Alliance for Hippocratic Medicine v. FDA, stayed the FDA's approval of mifepristone, one of two medications used most commonly for medication abortion in the U.S. While stopping short of a full injunction, the court's action threatens access to an important form of abortion care.
Mifepristone wa . . .
* * *
A federal judge in Texas, in the case Alliance for Hippocratic Medicine v. FDA, stayed the FDA's approval of mifepristone, one of two medications used most commonly for medication abortion in the U.S. While stopping short of a full injunction, the court's action threatens access to an important form of abortion care.
Mifepristone wa . . .